Ruicheng Wu

451 total citations · 1 hit paper
43 papers, 219 citations indexed

About

Ruicheng Wu is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Ruicheng Wu has authored 43 papers receiving a total of 219 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 14 papers in Surgery and 14 papers in Oncology. Recurrent topics in Ruicheng Wu's work include Bladder and Urothelial Cancer Treatments (12 papers), Ferroptosis and cancer prognosis (9 papers) and Inflammatory Biomarkers in Disease Prognosis (6 papers). Ruicheng Wu is often cited by papers focused on Bladder and Urothelial Cancer Treatments (12 papers), Ferroptosis and cancer prognosis (9 papers) and Inflammatory Biomarkers in Disease Prognosis (6 papers). Ruicheng Wu collaborates with scholars based in China, South Korea and United Kingdom. Ruicheng Wu's co-authors include Dengxiong Li, Dechao Feng, Jie Wang, Wuran Wei, Qingxin Yu, Zhouting Tuo, Koo Han Yoo, Luxia Ye, Ping Han and William C. Cho and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Cancer and Frontiers in Immunology.

In The Last Decade

Ruicheng Wu

39 papers receiving 219 citations

Hit Papers

The Common Hallmarks and Interconnected Pathways of Aging... 2025 2026 2025 5 10 15
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Common Hallmarks and Interconnected Pathways of Aging, Circadian Rhythms, and Cancer: Implications for Therapeutic Strategies
    2025 16 citations Qingxin Yu, Luxia Ye et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruicheng Wu China 10 90 59 55 50 48 43 219
Zhouting Tuo China 10 133 1.5× 65 1.1× 61 1.1× 60 1.2× 36 0.8× 45 279
Xu Shi China 12 146 1.6× 165 2.8× 58 1.1× 153 3.1× 28 0.6× 24 316
Alizée Vercauteren Drubbel Belgium 5 144 1.6× 19 0.3× 119 2.2× 62 1.2× 19 0.4× 7 233
Sarah Middleton United States 7 133 1.5× 35 0.6× 22 0.4× 25 0.5× 23 0.5× 9 292
Kelei Gao China 11 80 0.9× 34 0.6× 53 1.0× 36 0.7× 76 1.6× 26 292
Giuseppe Mallel Israel 7 51 0.6× 25 0.4× 89 1.6× 36 0.7× 26 0.5× 12 187
Francesco Cambuli United Kingdom 5 122 1.4× 53 0.9× 68 1.2× 25 0.5× 22 0.5× 5 225
Hongya Xie China 8 175 1.9× 91 1.5× 47 0.9× 149 3.0× 46 1.0× 19 329
Jing Y. Krzeszinski United States 5 154 1.7× 15 0.3× 70 1.3× 50 1.0× 18 0.4× 6 257
Zan Tang China 5 104 1.2× 159 2.7× 18 0.3× 20 0.4× 86 1.8× 7 264

Countries citing papers authored by Ruicheng Wu

Since Specialization
Citations

This map shows the geographic impact of Ruicheng Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruicheng Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruicheng Wu more than expected).

Fields of papers citing papers by Ruicheng Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruicheng Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruicheng Wu. The network helps show where Ruicheng Wu may publish in the future.

Co-authorship network of co-authors of Ruicheng Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Ruicheng Wu. A scholar is included among the top collaborators of Ruicheng Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruicheng Wu. Ruicheng Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Ruicheng, Dengxiong Li, Zhouting Tuo, et al.. (2025). Expanding horizons in theragnostics: from oncology to multidisciplinary applications. La radiologia medica. 130(5). 613–628. 3 indexed citations
2.
Li, Dengxiong, Zhipeng Wang, Qingxin Yu, et al.. (2025). Tracing the Evolution of Sex Hormones and Receptor‐Mediated Immune Microenvironmental Differences in Prostate and Bladder Cancers: From Embryonic Development to Disease. Advanced Science. 12(13). e2407715–e2407715. 4 indexed citations
3.
Wang, Zhipeng, Luxia Ye, Ruicheng Wu, et al.. (2024). Basic helix–loop–helix ARNT like 1 regulates the function of immune cells and participates in the development of immune-related diseases. Burns & Trauma. 13. tkae075–tkae075. 7 indexed citations
4.
Li, Dengxiong, Qingxin Yu, Ruicheng Wu, et al.. (2024). Efficiency of transurethral en‐bloc resection vs. conventional transurethral resection for non‐muscle‐invasive bladder cancer: An umbrella review. Cancer Medicine. 13(11). e7323–e7323. 9 indexed citations
5.
Jiang, Zhiwei, Dengxiong Li, Ruicheng Wu, et al.. (2024). The application of 3D printing technology in tumor radiotherapy in the era of precision medicine. Applied Materials Today. 40. 102368–102368. 5 indexed citations
6.
Feng, Dechao, Jie Wang, Liying Zhang, et al.. (2024). Telemedicine‐medical “snack community”‐PHS ecosystem: Insights into the double‐edged sword role of telemedicine in clinical practice and medical education during the COVID‐19 pandemic and beyond. SHILAP Revista de lepidopterología. 4(4). 20230111–20230111. 1 indexed citations
7.
Wu, Ruicheng, Dengxiong Li, Shuxia Zhang, et al.. (2024). A pan-cancer analysis of the oncogenic and immunological roles of transglutaminase 1 (TGM1) in human cancer. Journal of Cancer Research and Clinical Oncology. 150(3). 123–123. 2 indexed citations
8.
9.
Che, Lu, Dengxiong Li, Jie Wang, et al.. (2024). Identification of circadian clock-related immunological prognostic index and molecular subtypes in prostate cancer. Discover Oncology. 15(1). 429–429. 1 indexed citations
10.
Feng, Dechao, Jie Wang, Ruicheng Wu, & Dengxiong Li. (2024). Re: Immune System and Intestinal Microbiota Determine Efficacy of Androgen Deprivation Therapy Against Prostate Cancer. European Urology. 85(5). 498–499. 3 indexed citations
11.
Li, Dengxiong, Xinrui Li, Qingxin Yu, et al.. (2024). Advancements and challenges of R-loops in cancers: Biological insights and future directions. Cancer Letters. 610. 217359–217359. 9 indexed citations
12.
Li, Dengxiong, et al.. (2024). A Prognostic Index Derived From LASSO-Selected Preoperative Inflammation and Nutritional Markers for Non–Muscle-Invasive Bladder Cancer. Clinical Genitourinary Cancer. 22(3). 102061–102061. 2 indexed citations
13.
Tuo, Zhouting, Ruicheng Wu, Jie Wang, et al.. (2024). Pan-cancer analysis of RNA 5-methylcytosine reader (ALYREF). Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 32(3). 503–515. 6 indexed citations
14.
Li, Dengxiong, Qingxin Yu, Ruicheng Wu, et al.. (2024). Chronobiology of the Tumor Microenvironment: Implications for Therapeutic Strategies and Circadian-Based Interventions. Aging and Disease. 16(2). 645–645. 10 indexed citations
15.
Feng, Dechao, Li Li, Dengxiong Li, et al.. (2023). Prolyl 4-hydroxylase subunit beta (P4HB) could serve as a prognostic and radiosensitivity biomarker for prostate cancer patients. European journal of medical research. 28(1). 245–245. 11 indexed citations
16.
Li, Dengxiong, Ruicheng Wu, Jie Wang, Dechao Feng, & Shi Deng. (2023). Prognostic potential of m7G-associated lncRNA signature in predicting bladder cancer response to immunotherapy and chemotherapy. ONCOLOGIE. 25(6). 729–742. 3 indexed citations
17.
Feng, Dechao, et al.. (2023). Focal ablation therapy presents promising results for selectively localized prostate cancer patients. Chinese Journal of Cancer Research. 35(4). 424–430. 15 indexed citations
18.
Feng, Dechao, Li Li, Xu Shi, et al.. (2023). Identification of senescence-related lncRNA prognostic index correlating with prognosis and radiosensitivity in prostate cancer patients. Aging. 15(18). 9358–9376. 5 indexed citations
19.
Feng, Dechao, Xu Shi, Dengxiong Li, et al.. (2023). M2 macrophage-related molecular subtypes and prognostic index for prostate cancer patients through integrating single-cell and bulk RNA sequencing analysis. Genes & Diseases. 11(4). 101086–101086. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhouting Tuo Breakdown of academic impact, for papers by Xu Shi Breakdown of academic impact, for papers by Alizée Vercauteren Drubbel Breakdown of academic impact, for papers by Sarah Middleton Breakdown of academic impact, for papers by Kelei Gao Breakdown of academic impact, for papers by Giuseppe Mallel Breakdown of academic impact, for papers by Francesco Cambuli Breakdown of academic impact, for papers by Hongya Xie Breakdown of academic impact, for papers by Jing Y. Krzeszinski Breakdown of academic impact, for papers by Zan Tang
Rankless by CCL
2026